RNASET2 tag SNP but not CCR6 polymorphisms is associated with autoimmune thyroid diseases in the Chinese Han population

BMC Medical Genetics

Volumn 16, Issue 1, 2015, Pages

  Chen, Xiao jun ^a   Gong, Xiao hua ^a   Yan, Ni ^b   Meng, Shuai ^b   Qin, Qiu ^b   Jiang, Yan Fei ^b   Zheng, Hai Yan ^b   Zhang, Jin an ^b  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b JINSHAN HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

Autoimmune thyroid diseases (AITDs); CCR6; Graves' disease (GD); Hashimoto's thyroiditis (HT); RNASET2; Single nucleotide polymorphisms (SNPs)

Indexed keywords

CHEMOKINE RECEPTOR CCR6; PROTEIN; PROTEIN RNASET2; UNCLASSIFIED DRUG; RIBONUCLEASE; RNASET2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CHINESE; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; ETHNICITY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; GRAVES DISEASE; HAPLOTYPE; HASHIMOTO DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; PHENOTYPE; POPULATION; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUP; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; ETHNIC GROUPS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GRAVES DISEASE; HAPLOTYPES; HASHIMOTO DISEASE; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CCR6; RIBONUCLEASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84924858509     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/s12881-015-0150-9     Document Type: Article

References (34)

1. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun. 2009;32:231-9.
2. Menconi F, Oppenheim YL, Tomer Y. Diagnostic Criteria in Autoimmune Diseases. Part V: Graves Disease; 2008. p. 231-5.
3. Tomer Y, Davies TF. Searching for the autoimmune thyroid disease susceptibility genes: from gene mapping to gene function. Endocr Rev. 2003;24(5):694-717.
4. Hodge SE, Ban Y, Strug LJ, Greenberg DA, Davies TF, Concepcion ES, et al. Possible interaction between HLA-DR β1 and thyroglobulin variants in Graves' disease. Thyroid. 2006;16(4):351-5.
5. Jacobson EM, Tomer Y. The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: Back to the future. J Autoimmun. 2007;28(2-3):85-98.
6. 49 SNPs are associated with autoimmune thyroid diseases in the Chinese population. Endocrine. 2012;41(1):111-5.
7. Tomer Y, Concepcion E, Greenberg DA. A C/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid. 2002;12(12):1129-35.
8. Liu L, Wu HQ, Wang Q, Zhu YF, Zhang W, Guan LJ, et al. Association between thyroid stimulating hormone receptor gene intron polymorphisms and autoimmune thyroid disease in a Chinese Han population. Endocr J. 2012;59(8):717-23.
9. Maierhaba M, Zhang JA, Yu ZY, Wang Y, Xiao WX, Quan Y, et al. Association of the thyroglobulin gene polymorphism with autoimmune thyroid disease in Chinese population. Endocrine. 2008;33(3):294-9.
10. Yan N, Yu YL, Yang J, Qin Q, Zhu YF, Wang X, et al. Association of interleukin-17A and -17F gene single-nucleotide polymorphisms with autoimmune thyroid diseases. Autoimmunity. 2012;45(7):533-9.
11. Zhang J, Xiao WX, Zhu YF, Muhali FS, Xiao L, Jiang WJ, et al. Polymorphisms of interleukin-21 and interleukin-21-receptor genes confer risk for autoimmune thyroid diseases. BMC Endocr Disord. 2013;29:13-26.
12. Kitamura K, Farber JM, Kelsall BL. CCR6 marks regulatory T cells as a colon-tropic, IL-10-producing phenotype. J Immunol. 2010;185(6):3295-304.
13. Schutyser E, Struyf S, Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev. 2003;14(5):409-26.
14. Liao F, Shirakawa AK, Foley JF, Rabin RL, Farber JM. Human B cells become highly responsive to macrophage-inflammatory protein-3 alpha/CC chemokine ligand-20 after cellular activation without changes in CCR6 expression or ligand binding. J Immunol. 2002;168(10):4871-80.
15. Lee AY, Körner H. CCR6 and CCL20: emerging players in the pathogenesis of rheumatoid arthritis. Immunol Cell Biol. 2014;92(4):354-8.
16. Lee AY, Eri R, Lyons AB, Grimm MC, Korner H. CC chemokine ligand 20 and its cognate receptor CCR6 in mucosal T cell immunology and inflammatory bowel disease: odd couple or axis of evil? Front Immunol. 2013;4:194.
17. Figueroa-Vega N, Alfonso-Pérez M, Benedicto I, Sánchez-Madrid F, González-Amaro R, Marazuela M. Increased circulating pro-inflammatory cytokines and Th17 lymphocytes in Hashimoto's thyroiditis. J Clin Endocrinol Metab. 2010;95(2):953-62.
18. Qin Q, Liu P, Liu L, Wang R, Yan N, Yang J, et al. The increased but non-predominant expression of Th17- and Th1-specific cytokines in Hashimoto's thyroiditis but not in Graves' disease. Braz J Med Biol Res. 2012;45(12):1202-8.
19. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42(6):508-14.
20. Kochi Y, Okada Y, Suzuki A, Ikari K, Terao C, Takahashi A, et al. A regulatory variant in CCR6 is associated with rheumatoid arthritis susceptibility. Nat Genet. 2010;42(6):515-9.
21. Barrett JC, Hansoul S, Nicolae DL, Cho JH, Duerr RH, Rioux JD, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40(8):955-62.
22. Koumakis E, Bouaziz M, Dieudé P, Ruiz B, Riemekasten G, Airo P, et al. A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis. Arthritis Rheum. 2013;65(12):3202-8.
23. Quan C, Ren YQ, Xiang LH, Sun LD, Xu AE, Gao XH, et al. Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC. Nat Genet. 2010;42(7):614-8.
24. Chu X, Pan CM, Zhao SX, Liang J, Gao GQ, Zhang XM, et al. genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet. 2011;43(9):897-901.
25. Yan N, Meng S, Zhou J, Xu J, Muhali FS, Jiang W, et al. Association between STAT4 Gene Polymorphisms and Autoimmune Thyroid Diseases in a Chinese Population. Int J Mol Sci. 2014;15(7):12280-93.
26. Dupont WD, Plummer Jr WD. Power and sample size calculations for studies involving linear regression. Control Clin Trials. 1998;19(6):589-601.
27. Salazar-Gonzalez RM, Niess JH, Zammit DJ, Ravindran R, Srinivasan A, Maxwell JR, et al. CCR6-mediated dendritic cell activation of pathogen-specific T cells in Peyer's patches. Immunity. 2006;24(5):623-32.
28. Jin Y, Birlea SA, Fain PR, Mailloux CM, Riccardi SL, Gowan K, et al. Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet. 2010;42(7):576-8.
29. Teng E, Leong KP, Li HH, Thong B, Koh ET, Loi PL, et al. Analysis of a genome-wide association study-linked locus (CCR6) in asian rheumatoid arthritis. DNA Cell Biol. 2012;31(4):607-10.
30. Yi X, Du L, Hou S, Li F, Chen Y, Kijlstra A, et al. FGFR1OP tag SNP but not CCR6 polymorphisms are associated with vogt-koyanagi-harada syndrome in Chinese Han. PLoS One. 2013;8(7):e69358.
31. Yi X, Yang P, Du L, Jiang Z, Li F. There is no association of CCR6 polymorphisms with susceptibility toBehcet's disease in two Chinese Han populations. Br J Ophthalmol. 2011;95(11):1603-6.
32. Steinfelder S, Andersen JF, Cannons JL, Feng CG, Joshi M, Dwyer D, et al. The major component in schistosome eggs responsible for conditioning dendritic cells for Th2 polarization is a T2 ribonuclease (omega-1). J Exp Med. 2009;206(8):1681-90.
33. Szymański K, Bednarczuk T, Krajewski P, Ploski R. The replication of the association of the rs6832151 within chromosomal band 4p14 with Graves' disease in a Polish Caucasian population. Tissue Antigens. 2012;79(5):380-3.
34. Ban Y, Tozaki T, Taniyama M. The replication of the association of the rs9355610 within 6p27 with Graves' disease. Autoimmunity. 2013;46(6):395-8.